Rocket Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
RCKT chart
What traders are saying about $RCKT
Latest postsRocket Pharmaceuticals, Inc. news
- Form 144 ROCKET PHARMACEUTICALS For: 10 November By Investing.com
Investing.com Canada ·
- Rocket Pharmaceuticals, Inc. (9IP1.F) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Rocket Pharmaceuticals Officer Sarbani Chaudhuri Announces Planned Sale of 4,872 Shares
Kalkine Media ·
- An officer proposes selling 4,872 Rocket Pharmaceuticals (RCKT) shares after stock vesting.
Stock Titan ·
- Rocket Pharmaceuticals Stock Price Forecast. Should You Buy RCKT?
StockInvest.us ·
- An officer plans to sell 53,389 Rocket Pharmaceuticals (RCKT) shares, including shares to cover taxes.
Stock Titan ·
- Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference
Yahoo Finance ·
- Rocket Pharmaceuticals shares rise 4% after securing access to $150 million credit facility
proactiveinvestors.com ·
- Rocket Pharmaceuticals Highlights FDA-Aligned Pivotal Phase 2 Trial and Updated Clinical Findings for RP-A501 Following Danon Disease Investor Webinar
Yahoo Finance ·
- MARKETS LIVE: Wall Street ends lower as 30-year Treasury yield hits 2002 high
proactiveinvestors.com ·
- Rocket receives $150m credit facility to advance cardiovascular portfolio
pharmaceutical-technology.com ·
- Rocket Pharmaceuticals Details RP-A501 Pivotal Plan After Safety Reset
marketbeat.com ·
Rocket Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net income | -$223.1M | -$258.7M | -$245.6M | -$221.9M |
| Diluted EPS | $-2.01 | $-2.73 | $-2.92 | $-3.26 |
| Total assets (year end) | $330.4M | $527.7M | $566.3M | $551.8M |
| Cash and equivalents (year end) | $77.6M | $163.6M | $55.9M | $140.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Rocket Pharmaceuticals, Inc.
- Ticker
- RCKT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1281895
- Former names
- INOTEK PHARMACEUTICALS CORP
Frequently asked questions
What exchange is Rocket Pharmaceuticals, Inc. listed on?
Rocket Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol RCKT.
What industry is Rocket Pharmaceuticals, Inc. in?
Rocket Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Rocket Pharmaceuticals, Inc. headquartered?
Rocket Pharmaceuticals, Inc.'s business address on file with the SEC is in New York, NY.
When does Rocket Pharmaceuticals, Inc.'s fiscal year end?
Rocket Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Rocket Pharmaceuticals, Inc. report?
Rocket Pharmaceuticals, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.